Clik here to view.
AVITA Medical Named One of the Most Innovative Companies of 2018 by PM360
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that PM360, a leading trade magazine for marketing...
View ArticleClik here to view.
武田宣布美国存托股票在纽约证券交易所上市
日本大阪 (美国商业资讯)–如在任何司法管辖区内直接或间接发布、出版或分发全部或部分内容构成违反该司法管辖区有关法律的行为，则不得在此等司法管辖区从事该行为。 武田药品工业株式会社(TSE:...
View ArticleClik here to view.
武田薬品がニューヨーク証券取引所への米国預託株式の上場を発表
大阪 （ビジネスワイヤ） — 本情報の全部または一部の直接的または間接的な公開、出版、配布が関係する法律の違反となる国・地域においては、そのような公開、出版、配布を禁止します。...
View ArticleClik here to view.
HitGen and Bayer Enter DNA-Encoded Library Based Research Collaboration
CHENGDU, China HitGen Ltd announced that the company has entered into a research collaboration with the Crop Science division of Bayer to identify novel small molecule leads for targets of interest....
View ArticleClik here to view.
Macrogen Becomes the First Clinical Lab in Korea to Receive CLIA Accreditation
SEOUL, South Korea The precision medicine and biotechnology company, Macrogen (CEO Kap-Seok Yang, www.macrogen.com) (KOSDAQ: 038290), announced on December 20 that its NGS clinical laboratories in...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Sevelamer Carbonate for Oral...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View ArticleClik here to view.
22ndセンチュリーが超低ニコチン紙巻たばこのリスク低減たばこ製品（MRTP）申請をFDAに提出
米ニューヨーク州ウィリアムズビル （ビジネスワイヤ） — たばこの有害性低減と超低ニコチン（VLN）たばこに取り組む植物バイオテクノロジー企業の22ndセンチュリー・グループ（NYSE American:...
View ArticleClik here to view.
Promethera Biosciences Announces Investment by ITOCHU Corporation and a Broad...
MONT-SAINT-GUIBERT, Belgium & TOKYO Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced a strategic investment of EUR10 million by ITOCHU...
View ArticleClik here to view.
22nd Century向FDA递交该公司极低尼古丁含量香烟的改良风险烟草产品(MRTP)申请
纽约州威廉斯维尔 (美国商业资讯) — 专注于烟草减害和极低尼古丁烟草的植物生物技术公司22nd Century Group, Inc. (NYSE American: XXII)今天向美国食品药品管理局(FDA)递交了该公司极低尼古丁含量(VLNC)香烟的改良风险烟草产品(MRTP)申请。22nd...
View ArticleClik here to view.
Gynesonics Announces $75 Million Financing
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company and the developer of the Sonata System and other advanced, incision-free solutions for the treatment of uterine conditions, today...
View ArticleClik here to view.
Thousand Oaks Biopharmaceuticals Completes $45 Million Series A Financing to...
THOUSAND OAKS, Calif. & SHANGHAI Thousand Oaks Biopharmaceuticals, Inc. (“TOBIO”), a leading integrated global CMC organization including GMP cell culture media and biomanufacturing capabilities...
View ArticleClik here to view.
1ST Biotherapeutics and twoXAR Form Co-Development Collaboration to Discover...
SEONGNAM, South Korea & MOUNTAIN VIEW, Calif. 1ST Biotherapeutics, Inc., a preclinical-stage biotechnology company focused on neurodegenerative diseases, immuno-oncology, and orphan diseases,...
View ArticleClik here to view.
Takeda Announces Multiple Cell Therapy Collaborations to Advance the...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502) today announced new research collaborations in immuno-oncology (I-O), an area of key strategic focus...
View ArticleClik here to view.
Takeda Notes Court Sanction of the Scheme of Arrangement with Respect to the...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) notes Shire plc’s (“Shire”) announcement that the Royal Court of Jersey (the “Jersey Court”) has today sanctioned...
View ArticleClik here to view.
CES 2019 Pitch Competition Featuring Shark Tank’s Daymond John Presented by...
LAS VEGAS The first annual CES Pitch Competition to highlight technology creating social connection was announced today by the Consumer Technology Association (CTA) Foundation and AARP. Kicking off...
View ArticleClik here to view.
GI Dynamics Appoints Vice President of Clinical and Regulatory Affairs
BOSTON & SYDNEY GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce the appointment of...
View ArticleClik here to view.
澳斯康生物完成4500万美元的A轮融资，以扩大一体化CMC，并在中国建设世界上最大的细胞培养生产厂
加州THOUSAND OAKS和上海 (美国商业资讯)– 澳斯康生物制药（海门）有限公司(Thousand Oaks Biopharmaceuticals,...
View ArticleClik here to view.
Harbour BioMed Appoints Atul Deshpande, Ph.D. MBA, Chief Strategy Officer and...
SHANGHAI & CAMBRIDGE, Mass. & ROTTERDAM, Netherlands Harbour BioMed announced the appointment of Atul Deshpande, Ph.D. MBA, as Chief Strategy Officer and Head of U.S. Operations. Dr....
View ArticleClik here to view.
武田注意到法院已批准与收购夏尔公司有关的协议安排
日本大阪 (美国商业资讯)– 武田药品工业株式会社(Takeda Pharmaceutical Company Limited)(TSE:4502/NYSE:TAK)（简称“武田”）已注意到夏尔私人有限公司(Shire plc)（简称“夏尔”）的声明。该声明称，泽西岛皇家法院(Royal Court of...
View ArticleClik here to view.
武田宣布多项细胞疗法合作，以推进公司的新型免疫肿瘤学阵容
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社（“武田”）(TSE: 4502)今天宣布新的免疫肿瘤学(I-O)研究合作，这是该公司关键战略重点领域。通过上述合作，武田寻求加快发现下一代癌症免疫治疗药物，包括新型细胞疗法，该方法有望为满足难治性癌症患者需求提供重要机遇。 武田肿瘤治疗领域部主管Phil Rowlands,...
View Article